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Exposure of gastric epithelial cells to the bacterial carcinogen Helicobacter pylori causes
DNA double strand breaks. Here, we show that H. pylori-induced DNA damage occurs co-
transcriptionally in S-phase cells that activate NF-κB signaling upon innate immune recog-
nition of the lipopolysaccharide biosynthetic intermediate β-ADP-heptose by the ALPK1/TIFA
signaling pathway. DNA damage depends on the bi-functional RfaE enzyme and the Cag
pathogenicity island of H. pylori, is accompanied by replication fork stalling and can be
observed also in primary cells derived from gastric organoids. Importantly, H. pylori-induced
replication stress and DNA damage depend on the presence of co-transcriptional RNA/DNA
hybrids (R-loops) that form in infected cells during S-phase as a consequence of β-ADP-
heptose/ ALPK1/TIFA/NF-κB signaling. H. pylori resides in close proximity to S-phase cells in
the gastric mucosa of gastritis patients. Taken together, our results link bacterial infection and
NF-κB-driven innate immune responses to R-loop-dependent replication stress and DNA
damage.
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bservational studies in humans first described a link
between infection with the human gastric pathogen
Helicobacter pylori and gastric cancer in the early
1990’s1,2. This discovery led to the categorization of H. pylori as a
class I (highest class) carcinogen by the World Health Organi-
zation in 1994. A causal link between H. pylori infection and
gastric adenocarcinoma was later confirmed in experimental
models using Mongolian gerbils3 and inbred mouse strains4,5,
especially in settings of hypergastrinemia6 or a high salt diet7.
Gastric H. pylori-induced carcinogenesis is preceded by a series of
precursor lesions that manifest as chronic inflammation, atrophy,
intestinal metaplasia, and dysplasia8. The H. pylori type IV
secretion system (T4SS), which is encoded by the Cag patho-
genicity island (Cag-PAI), and its T4SS-translocated effector
CagA have been described as major risk factors of gastric cancer
and its precursor lesions in observational studies in humans9 and
in experimental models10,11. As a consequence of a large body of
evidence implicating H. pylori in gastric carcinogenesis, screening
programs using upper gastrointestinal tract endoscopy are now in
place in countries with a particularly high gastric cancer burden,
such as South Korea or Japan. These programs have allowed
for early detection of gastric cancer and have reduced mortality
from this disease12. Eradication therapy targeting H. pylori is
efficacious at reducing gastric cancer risk, especially if it is applied
in patients with non-atrophic or atrophic gastritis but without
evidence of metaplasia13. A recent study has shown that even
patients with early gastric cancers that are limited to the gastric
mucosa or submucosa can benefit from eradication therapy, as
they show a lower risk of progressing to metachronous gastric
cancer than non-eradicated controls14.
We and others have demonstrated in several independent
studies that H. pylori induces DNA double-strand breaks (DNA
DSBs) in gastric epithelial cells in vitro and in vivo15–17. DNA
DSB induction in H. pylori-exposed cells depends on a functional
T4SS16–18 and preferentially occurs in transcribed regions of the
genome17. Whereas translocation of the only described protein
substrate of the T4SS, CagA, does not contribute to DNA DSB
induction, the depletion of NF-κB subunits strongly reduces DNA
DSB formation, suggesting that H. pylori-induced DNA damage
is driven by active transcription of NF-κB target genes, which in
turn is Cag-PAI-dependent18. Interestingly, a reduction in the
level of H. pylori-induced DSBs is also observed upon depletion of
the nucleotide excision repair endonucleases XPG and XPF18 that
have been shown to cleave co-transcriptional RNA/DNA hybrids,
termed R-loops19,20.
The earliest immune response to H. pylori is initiated by
gastric epithelial cells, to which H. pylori adheres tightly in vitro
and in vivo. Gastric epithelial cells sense H. pylori through a
recently described innate immune defense pathway that is
comprised of a sensor, the alpha-kinase 1 (ALPK1), and a sig-
naling adaptor, the tumor necrosis factor receptor-associated
factor (TRAF)-interacting protein with forkhead-associated
domain (TIFA), which together initiate T4SS-dependent NF-κB
signaling21–24. The pathway is activated upon T4SS-dependent
delivery of either D-glycero-beta-D-manno-heptose 1,7-bispho-
sphate (HBP) or ADP-beta-D-manno-heptose (β-ADP-heptose)
into the host cell21–24; both molecules are metabolic precursors
of lipopolysaccharide (LPS) biosynthesis. The binding of β-ADP-
heptose, and possibly of β-ADP-heptose 7-P (generated in the
host cell from HBP), to ALPK1 stimulates its kinase domain to
phosphorylate and activate TIFA24,25, which forms large com-
plexes (TIFAsomes) that also include interactors such as
TRAF222. H. pylori mutants that lack the ability to produce HBP
or β-ADP-heptose are incapable of activating the ALPK1/
TIFA pathway22,23; conversely, the extracellular addition of
β-ADP-heptose alone is sufficient to activate NF-κB signaling in
an ALPK1/TIFA-dependent manner24. Other Gram-negative
pathogens are sensed via the same pathway; these include Sal-
monella typhimurium, Shigella flexneri26, Yersinia pseudotu-
berculosis25 as well as Neisseria meningitidis and Neisseria
gonorrhoeae, for which the pathway was first described27. In the
case of all these pathogens, the activation of the ALPK1/TIFA
signaling axis lead to NF-κB activation and the subsequent
production of pro-inflammatory cytokines and chemokines, of
which the most often investigated example was IL-8.
As DNA damage induced by H. pylori is dependent on NF-κB
activation, and NF-κB activation is now known to be triggered by
the ADP-heptose/ALPK1/TIFA axis, we set out here to investi-
gate a possible link between the two processes and to elucidate in
detail the molecular mechanism of H. pylori-induced DNA
damage.
Results
H. pylori induces ALPK1/TIFA/NF-κB-dependent DNA
damage. To investigate whether the β-ADP-heptose/ALPK1/
TIFA signaling axis is involved in H. pylori-induced DNA
damage, we took advantage of AGS gastric epithelial cells that
were either proficient or deficient for ALPK1 and TIFA expres-
sion due to genetic ablation of the respective loci by CRISPR/Cas9
technology21. Cells were infected with wild-type H. pylori and
were subjected to immunofluorescence microscopy to quantify
53BP1 and γH2AX foci, which identify sites of DNA DSBs. In
wild-type AGS cells, H. pylori exposure induced multiplicity-of-
infection (MOI)-dependent DNA damage, which could be
observed as early as 6 h post infection (Fig. 1a, b, Supplementary
Data 1 and 2). The genetic ablation of ALPK1 or TIFA in AGS
cells strongly reduced DNA DSBs as judged by quantification of
53BP1/γH2AX foci (Fig. 1a, b). DNA damage was limited to cells
in S-phase, which were identified by PCNA staining (Fig. 1b,
Supplementary Fig. 1a, Supplementary Data 2 and 3) and was
also observed with a second strain of H. pylori (Supplementary
Fig. 1b). Plotting the signal intensities of PCNA over DAPI,
which readily separates cells in G1, S, and G2/M phases of the cell
cycle, confirmed that cells with five and more 53BP1 foci are
typically in S-phase (Fig. 1c). To rule out that off-target effects of
genome-editing by CRISPR led to the reduction in 53BP1 foci, we
took advantage of a second, independently generated ALPK1-
deficient AGS line published previously22 and of TIFA-deficient
AGS cells that had been complemented by transduction with a
lentivirus containing the complete TIFA coding sequence21. In
these complemented cells, TIFA expression is driven by the len-
tiviral MND promoter and completely restores IL-8 production
upon co-culture with H. pylori21. When subjected to H. pylori
exposure followed by 53BP1 staining and the quantification of
53BP1 foci, the second ALPK1-deficient cell line phenocopied
the effects of the first one (Supplementary Fig. 1c); TIFA-
complemented cells exhibited an almost complete restoration of
53BP1 foci formation, whereas the baseline levels (uninfected
condition) were unchanged (Supplementary Fig. 1c). These
results indicate that the resistance of ALPK1- or TIFA-deficient
AGS cells to H. pylori-induced DNA damage is indeed due to
TIFA ablation and not off-target effects of CRISPR.
A second readout of DNA damage, for which extracted nuclear
DNA was separated by pulsed-field gel electrophoresis, confirmed
that wild-type AGS cells sustain more DNA DSBs upon H. pylori
exposure than their ALPK1- or TIFA-deficient counterparts
(Fig. 1d, e, Supplementary Data 4). The differential induction of
DNA damage as observed in both readouts was mirrored by
differential IL-8 production, which, as published previously21–23,
was strongly dependent on ALPK1 and TIFA also in our
experiments (Fig. 1f). As the activation of ALPK1/TIFA results in
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NF-κB activation, we asked whether the inhibition of NF-κB
activation, or generally the inhibition of transcription, would
prevent H. pylori-induced DNA damage. Indeed, the exposure of
cells to an irreversible inhibitor of IKK-α, BAY 11-7082, which
prevents phosphorylation of IκBα and the translocation of NF-κB
to the nucleus, was as efficient as ALPK1 or TIFA deletion in
abrogating the formation of 53BP1 foci in S-phase cells upon H.
pylori infection (Fig. 2a, b, Supplementary Fig. 2a). Application of
the transcription inhibitor triptolide, a natural product extracted
from the Chinese plant Tripterygium wilfordii that is known to
block RNA polymerase II activity28, had similar effects on DNA
damage induction by H. pylori as NF-κB inhibition (Fig. 2a, b).
Interestingly, application of the canonical NF-κB activator TNF-α
did not result in DNA damage (Fig. 2a, b), even at concentrations
that trigger IL-8 secretion at levels comparable to those induced
by H. pylori infection (Fig. 2c). The consequences of H. pylori
infection on genomic integrity were comparable in magnitude to
DNA damage induced by the topoisomerase inhibitor camp-
tothecin (CPT), the effects of which were however not limited to
S-phase cells (Fig. 2a, b, Supplementary Fig. 2a). All results
combined indicate that activation of the ALPK1/TIFA/NF-κB
signaling axis by H. pylori triggers DNA damage in target cells
that appears to be specific to this pathway of NF-κB activation,
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Fig. 1 H. pylori induces DNA DSBs in gastric epithelial cells that depend on ALPK1/TIFA signaling and occur in S-phase. a–c Wild-type (CTRL), ALPK1-
deficient (ΔALPK1), and TIFA-deficient (ΔTIFA) AGS cells were infected for 6 h with H. pylori strain P12 at multiplicities of infection (MOIs) of 20 and 50
(or left untreated, UTR) and subjected to immunofluorescence staining for phosphorylated H2AX (γH2AX), 53BP1 and PCNA. DAPI was used to stain
nuclei. Representative images are shown in a for one PCNA-positive cell per condition, alongside scatter dot plots of the number of 53BP1 foci per nucleus
of >553 and up to 650 cells per condition for PCNA+ and PCNA− cells of the indicated genotypes in b. Data in b are pooled from three independent
experiments. Red lines indicate medians. In c, the PCNA and DAPI signal intensities of ~600 uninfected and as many H. pylori-infected (MOI 50) wild-type
cells were plotted to visualize cell cycle phase (G1, S, G2/M). The color code indicates the number of 53BP1 foci/nucleus. Scale bar in a, 10 μm. d–f Wild-
type (CTRL), ALPK1-deficient (ΔALPK1), and TIFA-deficient (ΔTIFA) AGS cells were infected for 6 h as described above and subjected to PFGE. A
representative gel is shown in d alongside the quantification of three gels in e. Fragmented DNA was normalized to the intact DNA retained in the slot, and
to the uninfected control condition, which was set as 100%. IL-8 secretion as assessed by ELISA is shown in f. In e and f, data are represented as mean
+/− SEM of four independent experiments. In f, data are represented as mean +/− SEM of three independent experiments. P-values were calculated by
one-way ANOVA with Dunn’s multiple comparisons correction. ns, not significant; *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.0001.
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in actively replicating (S-phase) cells. As NF-κB activation and
the resulting production of reactive oxygen species (ROS),
through mechanisms involving inducible nitric oxide synthase
(iNOS) and other inflammatory enzymes, have been implicated in
H. pylori-induced DNA damage29, we addressed this possibility
experimentally using the antioxidant N-acetyl-cysteine. We found
that H. pylori induces ROS, as judged by their flow cytometric
detection and quantification (Supplementary Fig. 2b, Supplemen-
tary Data 5). However, co-culturing AGS cells with H. pylori
in the presence of N-acetyl-cysteine—at concentrations that
completely abrogated ROS production—failed to reduce the DNA
damage as judged by 53BP1 foci formation (Supplementary
Fig. 2b–d). This result argues against a major contribution of ROS
to H. pylori-induced DNA damage in this setting.
To address whether H. pylori indeed resides in close proximity
to actively replicating cells in the human gastric mucosa, we
selected biopsies from six cases of H. pylori-associated gastritis
and three cases of normal (uninfected) gastric mucosa for
immunohistochemical analysis of H. pylori and of the prolifera-



























































































































































Fig. 2 H. pylori-induced DNA DSBs require active transcription and NF-κB activation. a–c Wild-type AGS cells were infected for 6 h with H. pylori P12 at
an MOI of 50 in the presence or absence of the NF-κB inhibitor BAY 11-7082 and the transcription inhibitor triptolide (1 μM and 100 nM final concentration,
respectively), or treated with 10 nM TNF-α or 100 nM camptothecin (CPT) for 6 h, and subjected to immunofluorescence staining for 53BP1 and PCNA.
Representative images are shown in a (scale bar, 10 μm) alongside scatter dot plots of >430 and up to 954 cells per condition in b. IL-8 secretion as
assessed by ELISA is shown in c. Data in b and c are pooled from four independent experiments. Red lines indicate medians. Data in c are represented as
mean+ SEM of three independent experiments. P-values were calculated by one-way ANOVA with Dunn’s multiple comparisons correction in b and by
two-way ANOVA with Tukey’s multiple comparisons correction in c. ns, not significant; *p < 0.05, ****p < 0.0001. d Immunohistochemical analysis of
H. pylori staining relative to Ki67+ cells in the gastric mucosa of patients presenting with (right panels) or without gastritis (left panels); six patients with
gastritis and three control patients were stained with very similar results. Hematoxylin and eosin (H&E)-stained sections are shown as well. Scale bars,
100 μm. Arrows point to areas where H. pylori resides in close proximity to proliferating cells.
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regions where H. pylori could be detected in close proximity to
Ki67+ cells in gastric glands; gastric glands typically exhibited
more Ki67+ cells than glands of uninfected controls (Fig. 2d).
These data indicate that areas of hyperproliferation are readily
detectable in the H. pylori-infected gastric mucosa, and H. pylori
resides in close proximity to proliferating cells.
H. pylori LPS biosynthetic intermediates induce DNA damage.
We next set out to assess which bacterial determinants are
required for DNA damage induction in addition to the above-
mentioned Cag-PAI/T4SS identified earlier16–18. The gene rfaE
(hldE; HP0858) of H. pylori encodes a bifunctional enzyme with
kinase as well as ADP transferase activity, forms a contiguous
operon with gmhA, gmhB, and rfaD, and is involved in the
synthesis of both HBP and ADP-heptose as intermediate meta-
bolites of LPS biosynthesis23. To examine whether rfaE is
required for DNA damage induction by H. pylori, we infected
AGS cells with the wild-type H. pylori strain P12 or its rfaE and
Cag-PAI mutants. The rfaE mutant induced less DNA damage as
determined by 53BP1 immunofluorescence microscopy than the
wild-type parental strain, and its phenotype resembled that of the
Cag-PAI mutant (Fig. 3a, b). Both mutants failed to induce IL-8
production by AGS cells (Fig. 3c); in contrast, the ability of the
rfaE mutant to deliver CagA and to thereby induce cell elonga-
tion and scattering was not compromised (Supplementary
Fig. 3a). The reduced DNA damage associated with rfaE mutant
infection could be confirmed using pulsed-field gel electro-
phoresis (Fig. 3d, e, Supplementary Data 6) and phenocopied
what was previously published for the Cag-PAI mutant18. As the
product of RfaE activity, β-ADP-heptose, has recently been
shown to enter host cells and activate ALPK124,25, we synthe-
sized the α- and β-anomers of ADP-heptose and determined the
consequences of their addition to AGS cells on genomic integrity.
The β-anomer, but not the α-anomer, induced DNA damage—as
judged by 53BP1 formation—as well as IL-8 secretion in a
ALPK1/TIFA-dependent manner (Fig. 3f, g, Supplementary
Fig. 3b); which was also confirmed by PFGE of fragmented DNA
(Supplementary Fig. 3c, d, Supplementary Data 7). As in the
context of live H. pylori infection, DNA damage upon β-ADP-
heptose exposure was limited to PCNA+ cells (Fig. 3f, Supple-
mentary Fig. 3b, e). The defect of the rfaE mutant could not be
rescued by addition of TNF-α (Supplementary Fig. 3f). The
combined results indicate that rfaE activity is required, and its
product β-ADP-heptose is sufficient, to induce the ALPK1/
TIFA-dependent DNA damage observed upon live H. pylori
infection of cultured gastric epithelial cells.
We next asked whether the findings could be recapitulated in a
gastric organoid model. Gastric organoids were grown from two
donors undergoing bariatric surgery30 and were subsequently
transformed into 2D cultures as previously described31. Infection
of primary cells from gastric organoids with wild-type bacteria,
but not the rfaE or Cag-PAI mutants, resulted in the production
and secretion of IL-8 into the culture supernatant (Supplementary
Fig. 3g). Exposure of the cells to the β- but not the α-anomer of
ADP-heptose elicited a similar IL-8 response as the wild-type H.
pylori infection (Supplementary Fig. 3g). Importantly, wild-type,
but not mutant bacteria-induced 53BP1 foci as judged by
immunofluorescence microscopy; as in AGS cells, this increase
in 53BP1 focus formation was restricted to S-phase cells identified
by PCNA foci (Fig. 3h, i, Supplementary Fig. 3h). The addition of
β- but not α-ADP-heptose phenocopied the effect of H. pylori
infection with respect to 53BP1 focus formation (Fig. 3h, i,
Supplementary Fig. 3h). The results from gastric organoid-
derived primary cells confirm that DNA damage occurs upon H.
pylori exposure also in this more physiological setting, is specific
to S-phase, depends on the H. pylori enzyme rfaE and the Cag-
PAI, and can be elicited by the addition of the ALPK1 ligand β-
ADP-heptose.
β-ADP-heptose/ALPK1/TIFA signaling induces replication
stress. Physical obstacles such as active transcription complexes
or DNA secondary structures are known to cause the slowing or
arrest of replication fork progression, a condition commonly
referred to as DNA replication stress32. To investigate whether
the DNA damage induced by H. pylori infection is linked to
replication stress, we employed a DNA fiber assay that exploits
the ability of eukaryotic cells to incorporate halogenated pyr-
imidine nucleoside analogs into replicating DNA and provides a
powerful tool to monitor genome-wide replication perturbations
at single-molecule resolution33. Ongoing replication events were
sequentially labeled with two thymidine analogs—chlorodeox-
yuridine (CldU) and iododeoxyuridine (IdU)—and individual
two-color labeled DNA tracts were visualized on stretched DNA
fibers by immunofluorescence microscopy (Fig. 4a, b). We found
that H. pylori infection led to slowing of replication fork pro-
gression in wild-type AGS cells as judged by measuring the
lengths of CldU tracts (Fig. 4b, c) and also by plotting replication
fork speeds (Supplementary Fig. 4a) that were calculated based on
the assumption that 1 μm of fiber corresponds to 2.59 kb34. As
replication fork slowing and shorter tracts can, in this assay, result
from two scenarios, i.e., either a slower overall DNA poly-
merization rate or increased frequency of fork stalling35, we
analyzed the fates of two (sister) replication forks emanating in
opposite directions from the same origin. To this end, we cal-
culated the ratio of the lengths of CldU tracts of sister replication
forks (length of the shorter tract divided by the length of longer
tract); in uninfected cells, the ratio was ~1, indicating that sister
forks traveled at similar speed. In H. pylori-infected AGS cells, the
ratio dropped to ~0.6, indicating fork asymmetry and selective
slowing/stalling of one fork only (Supplementary Fig. 4b).
Replication fork slowing was not only observed upon H. pylori
infection, but also upon treatment of AGS cells with the β- but
not the α-anomer of ADP-heptose (Fig. 4b, c, Supplementary
Fig. 4a). AGS cells lacking ALPK1 or TIFA expression were
resistant to replication fork slowing in this assay, both in the
setting of live infection and of exposure to β-ADP-heptose
(Fig. 4b, c, Supplementary Fig. 4a). Complementation of TIFA-
deficient AGS cells by TIFA overexpression from the lentiviral
MND promoter rescued the effects of live H. pylori infection on
fiber shortening (Supplementary Fig. 4c). The effect size of H.
pylori infection on replication fork progression was comparable to
the effects of the topoisomerase inhibitor camptothecin36, and to
the effects of the G quadruplex DNA (G4) ligand pyridostatin, a
well-known inducer of both DNA damage and genome instabil-
ity37, which served as our positive controls (Fig. 4d). The slowing
of replication forks upon H. pylori infection was dependent on
RfaE and the Cag-PAI, as both null mutants failed to cause CldU
tract shortening (Fig. 4e, f). TNF-α exposure did not cause CldU
tract shortening (Fig. 4e, f), and also failed to rescue the pheno-
type of the RfaE mutant (Supplementary Fig. 4d). Exposure of
infected cells to the NF-κB inhibitor BAY 11-7082 or to the
transcription inhibitor triptolide rescued H. pylori-induced fork
slowing (Fig. 4e, f). In contrast, treatment with the antioxidant N-
acetyl-cysteine did not prevent fork slowing (Supplementary
Fig. 4d). The combined results suggest that active transcription
driven by NF-κB as a consequence of β-ADP-heptose delivery
and ALPK1/TIFA signaling is a prerequisite of replication fork
slowing in H. pylori-infected cells; in contrast, ROS produced by
infected cells do not contribute to DNA damage or replication
stress.
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R-loop formation is required for replication stress. Active
replication and transcription that co-occur in the same regions of
the genome can result in replication stress and DNA damage if
both machineries collide. Replication fork stalling at sites of these
conflicts is caused by the formation of co-transcriptional R-
loops38–40. To address whether R-loop formation is the cause of
DNA damage and replication stress induced by H. pylori, we used
a cell line that conditionally expresses human RNase H141, an
enzyme that cleaves the RNA strand in RNA/DNA hybrids and
thereby eliminates R-loops. This cell line is derived from U2OS
osteosarcoma cells that have previously been shown to be sus-











































































































































































































































































































































Fig. 3 The bifunctional RfaE enzyme is required, and its product β-ADP-heptose is sufficient for the induction of DNA DSBs. a–c AGS cells were
infected for 6 h with H. pylori P12 or its isogenic RfaE and Cag-PAI mutants at an MOI of 50 and subjected to immunofluorescence staining for 53BP1 and
PCNA as well as DAPI. Representative images are shown in a alongside scatter dot plots of >730 and up to 1655 cells per condition in b. IL-8 secretion as
assessed by ELISA is shown in c. Data in b and c are pooled from four independent experiments. Red lines indicate medians. Data in c are represented as
mean+/− SEM of four independent experiments. Scale bar in a, 10 μm. d, e AGS cells were infected for 6 h as described above and subjected to PFGE. A
representative gel is shown in d alongside the quantification of three gels (independent experiments) in e. Fragmented DNA was normalized to the intact
DNA retained in the slot, and to the uninfected control condition, which was set as 100%. Data are presented as mean values+/− SEM. f, g Wild-type
(CTRL), ALPK1-deficient (ΔALPK1), and TIFA-deficient (ΔTIFA) AGS cells were exposed to α- or β-ADP-heptose at 0.5 μM final concentration for 6 h and
subjected to immunofluorescence staining for 53BP1 and PCNA as well as DAPI. Scatter dot plots of >579 and up to 706 cells per condition are shown in
f, with red lines indicating medians. IL-8 secretion as assessed by ELISA is shown in g. Data in f and g are pooled from four independent experiments.
P-values were calculated by one-way ANOVA with Dunn’s multiple comparisons correction. Data in g are presented as mean values+/− SEM. Scale bar,
10 μm. h, i Gastric organoids were transferred to 2D cultures and infected with the indicated strains of H. pylori P12 (MOI of 50) or exposed to α- or β-ADP-
heptose at 0.5 μM final concentration for 6 h. Cells were subjected to immunofluorescence staining for 53BP1 and PCNA as well as DAPI. Representative
images are shown in h of 53BP1 foci (scale bar, 10 μm), alongside scatter dot plots of >298 and up to 603 cells per condition for PCNA+ cells (in i). Data in
i are pooled from two independent experiments with cells derived from two different donors. Red lines indicate medians. P-values were calculated by one-
way ANOVA with Dunn’s multiple comparisons correction. ns, not significant; **p < 0.01, ***p < 0.005, ****p < 0.0001.
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commonly used in DNA damage research. Exposure of U2OS
cells to wild-type H. pylori for six hours induced the formation of
53BP1 foci that increased with the MOI and were specific to S-
phase, and were comparable in extent to those observed in AGS
cells (Fig. 5a, b, left panels −DOX, Supplementary Fig. 5a, b).
This DNA damage phenotype was accompanied by replication
fork slowing as determined by DNA fiber assay (Fig. 5c, d,
Supplementary Fig. 5c). As observed for AGS cells, replication
fork slowing in H. pylori-infected U2OS cells was dependent on a
functional Cag-PAI and RfaE, and could be completely reversed
by blocking transcription with the inhibitor triptolide or the NF-
κB inhibitor BAY 11-7082 (Supplementary Fig. 5d, e). Both DNA
damage in S-phase cells and replication stress could be induced
also in U2OS cells by the addition of β- but not α-ADP-heptose
(Fig. 5e–h, upper and left panels, −DOX, Supplementary Fig. 5f).
Importantly, the induction of RNase H1 expression by doxycy-
cline abrogated both 53BP1 foci formation (Fig. 5a, b, right
panels, +DOX) and replication fork slowing (Fig. 5c, d, lower and
right panels, +DOX, Supplementary Fig. 5c) upon H. pylori
































































































































































































































































Fig. 4 H. pylori induces DNA replication stress in host cells. a Schematic representation of the protocol used for the quantification of the length of newly
synthesized DNA tracts (fibers). b, c Wild-type (CTRL), ALPK1-deficient (ΔALPK1), and TIFA-deficient (ΔTIFA) AGS cells were either infected for 6 h with
H. pylori strain P12 (MOI of 50) or treated with 0.5 μM α- or β-ADP-heptose and then labeled sequentially with CIdU and IdU as shown in a. Representative
DNA fibers are shown in b and scatter dot plots of CIdU tract length (in μm) are shown in c for the indicated conditions. At least 106 and up to 318 fibers
were analyzed per condition. Data in c are pooled from two independent experiments. d Wild-type AGS cells were either infected for 6 h with H. pylori
strain P12 (MOI of 50) or treated with 100 nM camptothecin (CPT) or 10 μM pyridostatin (PDS) for 6 h and then labeled sequentially with CIdU and IdU as
shown in a. At least 200 fibers were analyzed per condition. Data in d are pooled from two independent experiments. e, f AGS cells were infected for 6 h
with either the wild-type H. pylori strain P12 or its isogenic RfaE and Cag-PAI mutants (MOI of 50) and/or treated with the NF-κB inhibitor BAY 11-7082
(1 μM), the transcription inhibitor triptolide (100 nM), or TNF-α (10 nM) and labeled sequentially with CIdU and IdU during the last 60min of infection as
shown in a. Representative DNA fibers are shown in e and scatter dot plots of CIdU tract length (in μm) are shown in f for the indicated conditions. At least
141 and up to 213 fibers were analyzed per condition. Data in f are pooled from two independent experiments. Red lines indicate medians throughout.
P-values were calculated throughout by one-way ANOVA with Dunn’s multiple comparisons correction. ns, not significant; *p < 0.05, ****p < 0.0001.
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Fig. 5 H. pylori-induced DNA damage and replication stress is prevented by overexpression of RNase H1. a, b U2OS cells were either infected for 6 h
with H. pylori P12 (MOI of 20 or 50), or treated with 100 nM camptothecin (CPT), and were treated or not with doxycycline (−/+ DOX) to induce the
expression of RNase H1. Cells were subjected to immunofluorescence staining for 53BP1 and PCNA as well as DAPI. Representative images are shown in
a alongside scatter dot plots of >1382 and up to 1752 cells per condition in b. Data in b are pooled from three independent experiments. c, d U2OS cells
were infected as described in a, b and additionally labeled sequentially with CIdU and IdU as shown in Fig. 4a for the assessment of replication tract length.
Representative DNA fibers are shown in c and scatter dot plots of CIdU tract length (in μm) are shown in d for the indicated conditions. At least 100 and up
to 500 fibers were analyzed per condition. Data in d are pooled from three independent experiments. e, f U2OS cells were exposed to α- or β-ADP-heptose
at 0.5 μM final concentration for 6 h and treated or not with doxycycline (−/+ DOX) to induce the expression of RNase H1. Cells were subjected to
immunofluorescence staining for 53BP1 and PCNA as well as DAPI. Representative images are shown in e alongside scatter dot plots of >1500 and up to
1752 cells per condition in f. Data in f are pooled from three independent experiments. Scale bar in a and e, 10 μm. g, h U2OS cells were exposed to α- or β-
ADP-heptose at 0.5 μM final concentration for 6 h, treated or not with doxycycline (−/+ DOX) to induce the expression of RNase H1, and additionally
labeled sequentially with CIdU and IdU for the assessment of DNA fiber tract length. Representative DNA fibers are shown in g and scatter dot plots of
CIdU tract length (in μm) are shown in h for the indicated conditions. At least 299 and up to 514 fibers were analyzed per condition. Data in h are pooled
from three independent experiments. Red lines indicate medians throughout. In b, d, f, and h, −DOX and +DOX samples of the same condition are color-
coded to facilitate comparisons. P-values were calculated by one-way ANOVA with Dunn’s multiple comparisons correction. ns, not significant; **p < 0.01,
***p < 0.005, ****p < 0.0001.
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The analysis of sister forks emanating from the same origin
showed that not only the slowing of fork progression, but also the
fork asymmetry associated with H. pylori infection, could be
reversed by induction of RNase H1 (Supplementary Fig. 5g, h).
The combined results implicate R-loops, processed by RNase H1,
in DNA damage and replication stress induced by H. pylori.
R-loops form in a Cag-PAI-, RfaE-, and NF-κB-dependent
manner. The dependence of DNA damage and replication stress
on R-loops prompted us to examine these structures in more
detail, and to address the prerequisites of their formation. To this
end, we used a cell line in the U2OS background that inducibly
expresses a GFP-tagged RNase H1 harboring a point mutation
(D210N) in its nuclease active site (RNase H1D210N/GFP)41,
rendering it enzymatically inactive. Such inactive RNase H1
molecules bind their target structures but fail to resolve them;
RNase H1D210N/GFP foci forming in this cell line thus report the
presence of R-loops. The addition of doxycycline to these reporter
cells and concomitant H. pylori infection led to the appearance of
on average 10–20 (and up to 80) RNase H1D210N/GFP foci per
cell that were not seen without doxycycline and that were clearly
dependent on the MOI (Fig. 6a, b, Supplementary Fig. 6a). The
extent of R-loop formation upon infection was comparable to that
induced by the topoisomerase inhibitor camptothecin (Fig. 6a, b),
a known inducer of R-loops19. RNase H1D210N/GFP foci did not
co-localize with sites of DNA damage (i.e., 53BP1 foci; Fig. 6a).
Treatment of the reporter cells with β-ADP-heptose, but not the
α-anomer, also resulted in R-loop formation (Fig. 6c, d) with a
similar effect size as observed for live H. pylori infection or
camptothecin treatment. Importantly, induction of expression of
the catalytically inactive mutant of RNase H1 failed to resolve H.
pylori- or β-ADP-heptose-induced DNA damage as assessed by
the quantification of 53BP1 foci (Fig. 6a, c, e), indicating that the
reduced DNA damage observed in settings of wild-type RNase
H1 overexpression indeed results from its enzymatic activity. R-
loop formation upon H. pylori infection was also abrogated by
inhibition of transcription with triptolide, and by inhibition of
NF-κB activation (Fig. 6f, g); the same treatments also blocked the
formation of DNA damage in U2OS cells (Fig. 6f, h), as shown
above for AGS cells (Fig. 2). The rfaE and Cag-PAI mutants of H.
pylori failed to induce RNase H1D210N/GFP foci (Fig. 6f, g).
Infection-induced RNase H1D210N/GFP foci were highly specific
for PCNA+ S-phase cells and were not observed in PCNA− cells
(Fig. 6a–h, Supplementary Fig. 6b, c). Interestingly, the induction
of RNase H1D210N/GFP foci and of DNA damage correlated
strongly with the level of incorporation of 5-fluorouracil (Sup-
plementary Fig. 6d), which was also strongly dependent on rfaE,
the Cag-PAI and NF-κB, and which we used as an indicator of
RNA synthesis. Staining of infected cells with an antibody spe-
cifically recognizing RNA/DNA hybrids (clone S9.6) confirmed
that infection with wild-type H. pylori, but not its rfaE and Cag-
PAI mutants, induces R-loops not only in U2OS cells as shown
with the reporter cell line, but also in AGS cells (Supplementary
Fig. 6e, f). Taken together, the results suggest that the active
transcription (of NF-κB target genes) that is induced by H. pylori
in an β-ADP-heptose/ALPK1/TIFA-dependent manner leads to
R-loop formation in actively replicating cells, possibly at sites
where the transcription and replication machineries collide.
H. pylori-infected cells show evidence of genotoxicity. Our
experimental data from two human cell lines as well as primary
gastric cells are consistent with the hypothesis that transcription/
replication conflicts generate substantial DNA damage during
H. pylori infection. Such widespread DNA damage, especially if
inadequately repaired, results in the subsequent accumulation of
mutations and an associated high risk of malignant transforma-
tion. As H. pylori is tightly associated with gastric carcinogenesis
both epidemiologically and in various animal models, we inves-
tigated possible links between DNA damage, mutational burden,
and gastric carcinogenesis. We first examined whether we would
find evidence for H. pylori-associated genotoxicity in AGS cells by
using the well-established cytokinesis-block micronucleus assay, a
simple and sensitive procedure for reading out chromosome
damage. AGS cells were treated, either already before or only
during infection, with cytochalasin B, an inhibitor of the mitotic
spindle that prevents cytokinesis. Cells that had completed one
division were identified by their binucleated appearance, and the
presence of small DAPI-stained fragments (micronuclei) that are
indicative of chromosome breaks or intact mis-segregated chro-
mosomes was quantified. We found up to three micronuclei per
H. pylori-infected AGS cell, and substantially more infected cells
exhibited evidence of micronuclei formation than control cells
(Fig. 7a, b). The RfaE mutant failed to induce micronuclei
(Fig. 7a, b), suggesting that H. pylori induces genotoxicity in an
RfaE-dependent manner. The extent of genotoxicity induced by H.
pylori would be expected to result in checkpoint activation, a DNA
damage response and apoptosis. However, infected cells did not
undergo apoptosis (Fig. 7c, d) and checkpoint activation— readout
as phosphorylation of the DNA damage sensor ATM and its target
KAP1— is very weak upon H. pylori infection relative to other
DNA damaging agents such as camptothecin (Supplementary
Fig. 7a, b, Supplementary Data 8–12). We conclude from these data
that the DNA damage induced by H. pylori, despite causing chro-
mosome breaks and mis-segregated chromosomes, fails to induce a
DNA damage response or apoptosis.
Higher mutational burden in H. pylori-associated gastric
cancer. We next asked whether gastric cancer genomic data
would possibly provide circumstantial evidence for the presence
of H. pylori as a driving force of malignant transformation. To
this end, we used the non-human transcript and genomic infor-
mation that is present in publicly accessible multi-omics (RNA-
sequencing, whole-genome sequencing, and whole-exome
sequencing) datasets of gastric cancer, which had been gener-
ated as part of the Cancer Genome Atlas (TCGA) project, to
annotate gastric cancer samples with their H. pylori status. We
had access to multi-omics datasets for 291 tumors from
treatment-naive gastric cancer patients that had previously been
subjected to array-based somatic copy number analysis, whole-
exome sequencing, and array-based DNA methylation profiling,
and that had resulted in the description of four major genetically
defined subtypes of gastric cancer42. These subtypes were EBV-
positive gastric cancer (characterized by the presence of EBV
genes and transcripts, a very low mutational burden and PIK3CA
mutations), microsatellite-instable gastric cancer (high muta-
tional burden, MSI high), chromosomally instable gastric cancer
(with large numbers of copy number variations and a high
mutational burden, and ubiquitous TP53 mutations) and geno-
mically stable gastric cancer (low mutational burden, diffuse type
by histology, early-onset, RHOA and ARHGAP6/26 somatic
genomic alterations)42. We were able to recapitulate the stratifi-
cation of the 291 patients into these subtypes (Fig. 7e). We found
evidence of H. pylori presence in all four subtypes, with 1/3 to 1/2
of patients of each subtype exhibiting evidence of H. pylori
transcripts or genomic DNA in either their tumor and/or adja-
cent tissue (Fig. 7e). When comparing the tumor mutational
burden of the four subtypes, we found that tumors from patients
with evidence of H. pylori infection (in either tumor and/or
adjacent tissue) of the most common MSI and CIN subtypes had
a higher mutational burden than those without H. pylori
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infection: within the CIN subtype, which with 136 samples was
the most common of the four gastric cancer subtypes in
the TCGA dataset, 57 H. pylori-infected patients had on average
2+/− 1.5 mutations per megabase, whereas this number was
1.54+/− 0.98 in the 79 H. pylori-negative patients (p= 0.052 as
determined by student’s T-test). Within the MSI subtype, the
figures were 20+/− 16 for 23 H. pylori-positive vs. 16+/− 7 for
33 H. pylori-negative patients, but the difference was not statis-
tically significant (p= 0.2). A total of 232 genes were differentially
affected by mutations as a function of H. pylori infection across all
291 samples (Supplementary Data 13, Fig. 7e).
We also looked specifically for mutations and copy number
variations (CNVs) in genes involved in R-loop prevention and



























































































































































































































































































































































































































Fig. 6 H. pylori induces R-loop formation that depends on NF-κB and active transcription. a, b U2OS cells were either infected for 6 h with H. pylori P12
(MOI of 20 or 50), or treated with 100 nM camptothecin (CPT), and were treated or not with doxycycline (−/+ DOX) to induce the expression of a
(D210N) mutant version of RNase H1 fused to GFP (RNH1D210N). Cells were subjected to immunofluorescence staining for 53BP1 and PCNA as well as
DAPI. Representative images are shown in RNH1D210N/GFP foci and 53BP1 foci, alongside scatter dot plots of RNH1D210N/GFP foci of >1468 and up to
1661 cells per condition in b; the −DOX panel shows lack of background signal in the GFP channel in the absence of RNH1D210N/GFP expression. Data in
b are pooled from three independent experiments. c, d U2OS cells were infected with H. pylori (MOI of 50) or exposed to α- or β-ADP-heptose at 0.5 μM
final concentration for 6 h and treated or not with doxycycline (−/+ DOX) to induce the expression of RNH1D210N/GFP. Cells were subjected to
immunofluorescence staining for 53BP1 and PCNA as well as DAPI. Representative images are shown in c of RNH1D210N/GFP foci and 53BP1 foci, alongside
scatter dot plots of RNH1D210N/GFP foci of >1326 and up to 1565 cells per condition in d. Data in d are pooled from three independent experiments.
e Scatter dot plots showing 53BP1 foci of >1000 and up to 3000 cells per condition of the U2OS cells shown in a and c, and their counterparts not treated
with doxycycline. f–h U2OS cells were infected with the indicated strains of H. pylori (MOI of 50) and/or exposed to the NF-κB inhibitor BAY 11-7082 (1
μM) or triptolide (100 nM) and treated with doxycycline to induce the expression of RNH1D210N/GFP. Cells were subjected to immunofluorescence
staining for 53BP1 and PCNA as well as DAPI. Representative images are shown in f of RNH1D210N/GFP foci and 53BP1 foci, alongside scatter dot plots of
RNH1D210N/GFP foci of >405 and up to 868 cells per condition in g, and of 53BP1 foci of >691 and up to 1042 cells per condition in h. Data in g and h are
pooled from three independent experiments. Red lines indicate medians throughout. P-values were calculated by one-way ANOVA with Dunn’s multiple
comparisons correction. ns, not significant; ***p < 0.005, ****p < 0.0001. Scale bars, 10 μm.
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predispose to gastric carcinogenesis. We plotted the mutations
and CNVs in 18 genes with functions in R-loop prevention or
processing relative to seven known gastric cancer driver genes,
i.e., CDH1, APC, TP53, ARID1A, PIK3CA, KRAS, and ERBB2, and
relative to the mutational burden per megabase. The 18 genes
with R-loop metabolism-related functions were selected based on
literature searches: we focused on the RNA/DNA helicases AQR,
SETX, and DHX9 involved in R-loop unwinding19,43,44, the DNA
helicase PIF1 known to prevent the accumulation of R-loops at
tRNA genes45, the DNA topoisomerase TOP3B, which also
prevents accumulation of R-loops46, the endonuclease RNASEH2
which, like RNase H1 cleaves the RNA strand in RNA/DNA
hybrids47, the splicing factor SRSF1, known to prevent R-
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Fig. 7 H. pylori induces micronuclei but not apoptosis in gastric epithelial cells and its presence is associated with specific mutational patterns in
gastric cancer. a, b Micronuclei formation as quantified in binucleated AGS cells that had been subjected to cytochalasin B treatment to prevent
cytokinesis, and had additionally been infected for 16 h with the indicated WT or RfaE mutant strains of H. pylori. Representative images are shown in a;
arrows point to micronuclei. Frequencies of binucleated (BN) cells with micronuclei are quantified in b and pooled from three independent experiments.
Data are presented as mean values+/− SEM. P-values were calculated by one-way ANOVA with Dunn’s multiple comparisons correction. Scale bar
represents 15 μm. c, d Annexin V staining for apoptosis of AGS cells infected with WT H. pylori, or treated with 5 μm staurosporine (STA) for 6 or 24 h.
Representative FACS plots are shown in c, and the quantification of Annexin V-positive cells of three independent experiments is shown in d. Data are
presented as mean values+/− SEM. P-values were calculated by two-way ANOVA with Tukey’s multiple comparisons correction. e Mutational signature
of H. pylori in gastric cancer as determined on 291 gastric cancer samples available through the Cancer Genome Atlas (TCGA). The H. pylori status was
annotated based on the presence of at least one unambiguous H. pylori-specific read detected in the transcriptome, whole genome or exome of either the
tumor or adjacent tissue of a total of 267 among the 291 patients. The gastric cancer subtype was assigned based on the previous description42 of CNVs,
presence of EBV transcripts, methylation of signature genes and microsatellite instability; the color code on the right indicates the four subtypes
chromosomally instable (CIN), microsatellite instable (MSI), EBV-positive (EBV), and genomically stable (GS). The heatmap shows the 232 genes found to
be differentially mutated between H. pylori-positive and -negative cases (p < 0.05 as determined by Student’s t-test); the majority of differentially mutated
genes are found in the MSI subtype. Genes are listed in Supplementary Table 1. ns, not significant; *p < 0.05, **p < 0.01.
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THO/TREX complex involved in mRNA export and R-loop
prevention49, the THO/TREX complex associated histone
deacetylase SIN3A50, and the six components of the TREX-2
complex that, with BRCA2, is also associated with mRNA export
and R-loop prevention51. Several of these genes were recurrently
(in up to 36% of gastric cancer cases) affected by CNVs and/or
missense or frameshift mutations, with the most recurrently
affected genes belonging to the TREX-2 complex (ENY2,
MCM3AP, SEM1, CETN3) or having RNA/DNA helicase or
endonuclease activity (SETX, AQR, DHX9, RNASEH2) (Supple-
mentary Fig. 7c). Mutations in R-loop metabolism genes were
largely predicted to be damaging mutations, and—not unexpect-
edly—were mostly detected in the microsatellite-instable subtype
of gastric cancer that exhibited the highest overall mutational
burden; CNVs affecting R-loop genes were mostly detected in the
chromosomally instable subtype (Supplementary Fig. 7c). In
conclusion, the mutational landscape of gastric cancer provides
circumstantial evidence for the hypothesis that H. pylori infection
favors chromosomal instability, and that the inactivation of genes
encoding helicases, RNases and other factors involved in R-loop
prevention or processing may be an early event in gastric
carcinogenesis, predisposing H. pylori-infected cells to aberrant
R-loop accumulation and its potentially deleterious consequences.
Discussion
It is now widely accepted that Gram-negative bacteria are sensed
by epithelial cells via their production of LPS biosynthetic
intermediates, which bind directly to ALPK1 to induce down-
stream TIFA/NF-κB signaling. The mechanisms through which
LPS intermediates such as HBP and β-ADP-heptose reach the
host cell cytosol likely differ across bacterial species and, in the
case of H. pylori, appear to involve a functional T4SS21–23. Our
data corroborate this notion, as the loss of a key enzyme (RfaE)
involved in HBP and β-ADP-heptose synthesis phenocopies the
loss of the T4SS-encoding Cag-PAI of H. pylori in all DNA-
damage-related settings examined here. Other functions of the
Cag-PAI, such as the delivery of the only known T4SS protein
substrate CagA, are unaffected by RfaE deficiency. We and others
have reported previously that the DNA damage induced by H.
pylori in its epithelial target cells is dependent on a functional
T4SS16–18, and is largely restricted to transcribed regions of the
genome17. These earlier observations are consistent with the
model emerging from the current findings, where co-occurring
active replication and transcription in S-phase cells leads to R-
loop formation, which is followed by the processing of both the
RNA and the DNA strands of the RNA/DNA hybrid by dedicated
enzymes (Supplementary Fig. 8). The nucleolytic processing of
DNA in such structures is in turn sensed by DNA repair factors
such as 53BP1 and can be readily visualized and quantified
by pulsed-field gel electrophoresis and immunofluorescence
microscopy.
NF-κB has emerged in the course of our studies as the dominant
transcription factor driving the early, ALPK1/TIFA-dependent
response to H. pylori. The increase in incorporation of 5-FU—which
served as our readout of de novo RNA synthesis— due to H. pylori
infection was almost completely blocked not only by a general
inhibitor of RNA-Pol II, but also by a highly specific inhibitor of NF-
κB nuclear translocation. The same treatments prevented R-loop
formation, replication fork slowing, and DNA damage. NF-κB was
initially established as a key molecular link between inflammation
and cancer52 by two seminal studies showing that NF-κB has tumor-
promoting properties in settings of inflammation-associated cancers
of the colon and the liver53,54. NF-κB promotes carcinogenesis in
such particularly susceptible organs through both tumor-cell-intrinsic
and -extrinsic mechanisms (recently reviewed in ref. 52). NF-κB on
the one hand acts directly in tumor cells by promoting the produc-
tion of reactive oxygen and nitrogen species, which induce DNA
damage and oncogenic mutations55 and by promoting cell survival
through the activation of anti-apoptotic genes such as BCL-XL and
BCL-256,57. On the other hand, NF-κB activation in various cell types
of the tumor microenvironment, especially myeloid cells and cancer-
associated fibroblasts, promotes tumor growth and dissemination
through the production of cytokines (with TNF-α and IL-6 being the
best-understood pro-tumorigenic NF-κB targets), chemokines, and
pro-angiogenic factors58. Our data additionally implicate NF-κB
activation in genomic instability through co-transcriptional R-loop
formation that is associated with replication stress and DNA damage.
Not every pathway to NF-κB activation is equally prone to R-loop
induction and DNA damage; we have extensively tested TNF-α,
which activates IKK and NF-kB via the TRADD, TRAF2, NIK sig-
naling axis59 and bypasses ALPK1 and TIFA, and never found evi-
dence of R-loops or DNA damage in this setting. TNF-α also fails to
synergize with the non-genotoxic RfaE mutant to induce DNA
damage. These results indicate that NF-κB signaling is required, but
not sufficient, to induce DNA damage in actively transcribing/
replicating cells.
Two scenarios are conceivable that are not easily distinguished
experimentally but would both explain R-loop formation in the
context of H. pylori-induced NF-κB activation. As shown by
multiple laboratories in various models systems—ranging from
bacteria, to yeast, to mammalian cells—R-loops may either form
as a consequence of head-on collisions between a replication fork
and transcription bubble as proposed previously, or alternatively,
may form in highly transcribed regions of the genome, where they
cause pausing of RNA-Pol II, which in turn blocks the progres-
sion of oncoming replication forks38,60–63. Irrespective of the
sequence of events, we find that R-loop accumulation upon H.
pylori exposure promotes S-phase-specific DNA damage, as
overexpression of RNase H1 reduces DNA damage and abrogates
replication stress. Both suppressive effects of RNase H1 require its
enzymatic activity as they are not observed with a catalytically
dead version of the enzyme. R-loops have been linked not only to
DNA damage, genomic instability, and chromosomal rearrange-
ments, but also to oncogenesis51,61,64–66. Increased transcrip-
tional activity resulting from oncogene activation is known to
promote R-loop accumulation and replication stress. This has
been well documented for HRASV12 overexpression, which
through elevated expression of the general transcription factor
TATA-box binding protein leads to increased RNA synthesis, R-
loop accumulation, replication fork slowing, and DNA damage66.
In breast cancer cells, R-loops accumulate and drive DNA
damage in heavily transcribed estrogen-induced genes, and
translocations and structural variants are found in genes induced
by estrogen signaling67. In the scenarios described by these two
studies, the transcriptional landscape of cancer cells appears to
dictate where DNA damage occurs through R-loop formation.
Future studies integrating data from ChIP-seq-based surveys (for
example, by pull-down of R-loop-associated DNA with the RNA/
DNA hybrid-specific antibody S9.6) with transcriptional profiling
and mutational data for gastric cancer and its precursor lesions
will reveal whether certain heavily transcribed (NF-κB-regulated)
loci are particularly prone to R-loop-dependent DNA damage
and mutagenesis.
Several molecular mechanisms have been implicated in R-loop-
induced DNA damage. On the one hand, persistent RNA/DNA
hybrids may compromise DNA repair by blocking access of DNA
repair factors to DNA DSBs68, or by reducing the efficiency of
DNA end resection, which determines whether repair proceeds
via homologous recombination or non-homologous end join-
ing69. An alternative mechanism that has been proposed to link
R-loops to DNA damage posits that nucleotide excision repair
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(NER) enzymes XPG and XPF cut the DNA in the RNA/DNA
hybrid, producing a single-strand gap that is converted into a
DSB by replication or additional strand breaks19. Having shown
previously that the depletion of XPF or XPG reduces DNA DSBs
upon H. pylori infection18, our combined data are consistent with
a model where the processing of R-loops by NER factors, rather
than compromised DNA repair in the face of R-loops, link R-loop
formation to DNA damage (Supplementary Fig. 8).
The physiological prevention and/or processing of R-loops
requires a number of factors (RNA processing and splicing fac-
tors, helicases and nucleases), some of which were found in this
study to be recurrently mutated or subject to copy number losses
in gastric cancer. In particular, the genes encoding RNase H2 and
the RNA/DNA helicase Aquarius (AQR), and genes encoding the
components of the TREX-2 mRNA export complex—all known
to be involved in R-loop processing or prevention45,51,60,70 were
recurrently subjected to CNVs or mutated in gastric cancer, and
especially in the microsatellite instable and chromosomally
instable subtypes of the disease. In agreement with the hypothesis
that H. pylori-induced DNA damage causes genotoxicity and
predisposes to mutagenesis, we find more mutations, and dif-
ferent mutation patterns, in gastric cancer samples of patients
with evidence of H. pylori presence at the time of diagnosis. As
the diagnosis of H. pylori presence in non-human sequences of
gastric cancer and adjacent tissue is prone to false-negative (not
so much false-positive) results, the differences observed in the
mutational burden need to be interpreted with caution; this is
especially true because H. pylori disappears from its gastric
niche as intestinal metaplasia and other gastric cancer precursor
lesions form. We propose that inactivating mutations or copy
number losses in genes involved in the prevention or elimina-
tion of R-loops are early events in gastric cancer that predispose
hyper-proliferating cells to H. pylori-induced R-loop accumu-
lation and DNA damage. Immunohistochemical staining of
consecutive sections for proliferating cells and for H. pylori
suggests that live bacteria may indeed come in direct contact
with replicating cells in gastric corpus glands of gastritis
patients. In summary, we propose here a mechanism of
transcription-associated R-loop formation linked to DNA
damage that may connect innate immunity to DNA damage,
and bacterial infection to carcinogenesis.
Methods
Cell culture, bacterial strains, and infection conditions. Wild-type AGS cells
(ATCC CRL 1739, a human gastric adenocarcinoma cell line) and AGS cells
subjected to TIFA and ALPK1 deletion by CRISPR, and to TIFA complementation
with the wild-type TIFA gene21,22 were grown in RPMI supplemented with 10%
fetal calf serum (FCS), 100 U/ml penicillin, and 100 μg/ml streptomycin. U2OS
(ATCC HTB96, a human osteosarcoma cell line) T-Rex cell lines carrying pAIO
vectors for the expression of RNase H1/GFP or RNase H1D210N/GFP were culti-
vated in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10%
FCS (Tet-free approved), 100 U/ml penicillin, and 100 μg/ml streptomycin,
50 μg/ml hygromycin B and 1 μg/ml puromycin. Doxycycline (1 ng/ml) was added
for 24 h to induce the expression of recombinant RNase H1 and to downregulate
the endogenous RNH1 expression. BAY 11-7082 and triptolide were purchased
from Sigma-Aldrich. H. pylori was grown on solid medium on horse blood agar
containing 4% Columbia agar base (Oxoid; Basingstoke), 5% defibrinated horse
blood (HemoStatLabs), 0.2% β-cyclodextrin, 5 μg/ml trimethoprim, 8 μg/ml
amphotericin B, 10 μg/ml vancomycin, 5 μg/ml cefsulodin, and 2.5 U/ml poly-
myxin B sulfate (all from Sigma-Aldrich) at 37 °C for 2 days under microaerophilic
conditions. For liquid culture, H. pylori was grown in Brucella broth (Difco)
containing 10% FBS (Life Technologies) with shaking in a microaerobic atmo-
sphere at 37 °C. Bacterial numbers were determined by measuring the optical
density at 600 nm, and bacteria were added to cells at an MOI of 20 or 50 for 6 h.
The following strains of H. pylori were used: G2771, P12 wild-type, P12ΔPAI72, and
P12ΔRfaE22. All H. pylori liquid cultures were routinely assessed by light micro-
scopy for contamination, morphology, and motility prior to use in infections.
Two-dimensional gastric organoid culture and H. pylori infection. Human
tissues were obtained from patients of the University Clinic, Wuerzburg. This study
was approved by the ethical committee of the University of Wuerzburg’s University
Clinic (approval 37/16). Gastric organoids were initiated from tissues30 and for
infection in 2D, were sheared to single cells and seeded in coated µ-slide coverslips
(IBIDI, 8 Well, Cat. No. 80826) in antibiotic-free culture medium: Advanced
Dulbecco’s modified Eagle medium (DMEM)/F12 supplemented with 10 mmol/L
HEPES, GlutaMAX, 1× B27, 1 mmol/L N-acetylcysteine, 50 ng/mL epidermal
growth factor (EGF) (all from Invitrogen, Waltham, MA), 10% noggin-conditioned
medium, 10% R-spondin1-conditioned medium, 50% Wnt-conditioned medium,
200 ng/mL fibroblast growth factor (FGF)10 (Peprotech, Hamburg, Germany),
1 nmol/L gastrin (Tocris, Bristol, UK), and 2 mmol/L transforming growth factor
(TGF)βi (A-83-01; Tocris). After seeding, 10 mmol/L rho-associated coiled-coil
forming protein serine/threoninekinase (RHOK) (Y-27632; Sigma-Aldrich) was
added. The medium was refreshed every 2–3 days. Liquid cultures of H. pylori were
prepared as described above. Cells were infected on day 7 or 8 at 50% confluency
with an MOI of 50 or treated with α-ADP-heptose and β-ADP-heptose, respec-
tively, at a final concentration of 0.5 μM for 6 h. Supernatants were collected for
ELISA. Cells were subjected to immunofluorescence microscopy.
Cytokinesis-block micronuclei assay. Cells were grown on autoclaved coverslips
and supplemented with 2 μg/ml Cytochalasin B prior to infection with Helicobacter
pylori (P12 wild-type, P12ΔRfaE) for 12 h. Cells were washed three times with 1×
PBS and then fixed with 4% paraformaldehyde for 15 min at RT. After washing
three times with 1× PBS cells were stained with 1 μg/ml DAPI diluted in distilled
water for 5 min at RT. Coverslips were mounted with Fluoromount-G mounting
medium (Invitrogen, 00-4958-02). Images were acquired with a Leica DM6B
fluorescent microscope. In each experiment micronuclei of at least 100 binucleated
cells were counted per condition.
Flow cytometric quantification of apoptosis and reactive oxygen species
formation. For quantification of reactive oxygen species, AGS cells were stained
with 25 μM 2′,7′-dichlorofluorescin diacetate (DCFDA, Abcam, ab113851) and
infected with Helicobacter pylori or treated with 50 μM Tert-Butyl Hydrogen
Peroxide (TBHP, Abcam, ab113851) for 6 h. Cells were harvested, resuspended in
1× PBS/1%BSA and subjected to flow cytometry. Apoptosis was quantified by
Annexin V staining. Cells were infected with Helicobacter pylori or treated with
5 μM Staurosporin for 6 or 24 h. After harvesting cells were stained with PE-Cy7-
labeled Annexin V (BioLegend, Cat No. 559934) diluted in 1x Annexin V Binding
buffer (BD Bioscience, Cat No 640950) for 15 min at RT in the dark. Data were
acquired on a CyAn ADP (Beckman Coulter) flow cytometer and analyzed with the
FlowJo software (TreeStar).
5-Fluorouridine incorporation and staining. Cells grown on coverslips were
infected with Helicobacter pylori or treated as described above and pulse-labeled
with 1 mM 5-Fluorouridine (F5130, Sigma-Aldrich) for the last 30 min of the
experiment. After incubation, cells were washed with PBS, pre-extracted with pre-
extraction buffer (25 mM Hepes-NaOH, pH 7.7, 50 mM NaCl, 1 mM EDTA, 3 mM
MgCl2, 0.3 M sucrose, 0.5% Triton X-100) for 5 min on ice and fixed with 4%
formaldehyde (F8775, Sigma-Aldrich) in PBS for 15 min (in the dark, room
temperature), washed with PBS and fixed with ice-cold methanol for 20 min (in the
dark, −20 °C). After fixation, coverslips were washed with PBS and blocked with
1% BSA in PBS for 10 min and then stained with mouse monoclonal anti-BrdU
antibody (clone BU-33, which recognizes 5-Fluorouridine, B2531, Sigma-Aldrich)
in 1% BSA in PBS and with polyclonal rabbit anti-PCNA antibody (ab18197,
Abcam) for 120 min. After washing with PBS, coverslips were incubated with Alexa
Fluor 568-conjugated secondary antibody (Invitrogen, a11031), AF647 goat anti-
rabbit (Invitrogen, a21245) in 1% BSA in PBS, counterstained with DAPI and
mounted using Fluoromount-G mounting media (Invitrogen). Images were cap-
tured on Olympus IX83 microscope equipped with ScanR imaging platform using
40×/0.9 NA dry objective. For analysis images were submitted to ScanR Analysis
software based on signal intensity for FU. Nuclei were identified based on the DAPI
signal. Approximately 1000 cells were measured per condition.
Immunofluorescence microscopy. Cells grown on autoclaved coverslips were
infected with Helicobacter pylori or treated as described above for 6 h. After the
infection/treatment, cells were washed three times with 1× PBS and then per-
meabilized for 5 min with pre-extraction solution (25 mM Hepes, pH 7.7; 50 mM
NaCl; 1 mM EDTA; 3 mM MgCl2; 300 mM sucrose, 0.5% Triton X-100) on ice.
After a brief wash with 1× PBS, cells were fixed with 4% paraformaldehyde for
15 min at RT in the dark. For PCNA immunofluorescence, after fixation with
paraformaldehyde, cells were washed three times with 1× PBS and then fixed with
ice-cold methanol for 20 min at −20 °C. After fixation, cells were washed three
times with 1× PBS and blocked in 1% BSA/1× PBS for 20 min at RT. Coverslips
were then incubated with appropriate primary antibodies diluted in 1% BSA/1×
PBS for 90 min at RT in dark. The following antibodies and dilutions were used:
anti-phospho Histone H2A.X (Ser139) mouse monoclonal (Millipore, 05-636-
AF647, 1:300), anti-53BP1 rabbit polyclonal (Santa Cruz, sc-33760, 1:300), and
anti-PCNA Mouse monoclonal (Santa Cruz, sc56, 1:250). Coverslips were washed
three times with 1× PBS and then incubated with secondary antibodies diluted in
1% BSA/1× PBS for 30 min at RT in dark. Secondary antibodies and dilutions were
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Alexa Fluor 488 Goat Anti-Rabbit IgG (Life Technologies, A11034, 1:400), Alexa
Fluor 568 Goat Anti-Rabbit (Life Technologies, A11036, 1:400), Alexa Fluor 568
Goat Anti-Mouse (Life Technologies, A11031, 1:400), Alexa Fluor 647 Goat Anti-
Rabbit (Life Technologies, A21245, 1:400), and Alexa Fluor 647 Goat Anti-Mouse
(Invitrogen, A21235, 1:400). After three washes with 1× PBS, coverslips were
stained with 1 μg/ml DAPI diluted in distilled water for 2 min at RT in dark.
Coverslips were mounted with Fluoromount-G mounting medium (Invitrogen,
00-4958-02). Images were acquired with a Leica DM6B fluorescent microscope or
Leica SP8 inverted confocal microscope. For the analysis of phosphorylated H2AX
signal and 53BP1 foci, automated image acquisition was performed on a IX83
microscope (Olympus) equipped with ScanR imaging platform using a 40×/0.9 NA
objective. The analysis of acquired images was performed using ScanR Analysis
software. For the analysis of RNH1-GFP foci, images were acquired using GE IN
Cell Analyzer 2500HS with a 40×/1.15 NA water-immersion objective and the
analysis was performed using CellProfiler 3.1.573. Nuclei were identified based on
the DAPI signal and the parameters of interest were analyzed for each nuclear
object using modules of the ScanR Analysis software or CellProfiler 3.1.5.
Pulsed-field gel electrophoresis (PFGE). For PFGE, cells were harvested,
embedded in 1.5% agarose plugs (5 × 105 cells/plug), digested in lysis buffer
(100 mM EDTA, 1% (w/v) sodium lauryl sarcosyne, 0.2% (w/v) sodium deox-
ycholate, 1 mg/ml proteinase K) at 37 °C for 48 h and washed in TE (20 mM Tris-
HCl (pH 8.0), 50 mM EDTA). Electrophoresis was performed for 23 h at 14 °C in
0.9% (w/v) pulsed-field-certified agarose (Bio-Rad) containing Tris-borate/EDTA
buffer according to the conditions described in ref. 74 and adapted to a Bio-Rad
CHEF DR III apparatus. Gels were stained with ethidium bromide and imaged on
an Alpha Innotech Imager. Two images were taken of each gel with 8 and 100 ms
exposure time, respectively. For quantification, the signal intensity of the frag-
mented DNA (which has migrated into the gel and formed a distinct band) after
100 ms exposure time was normalized to the signal intensity of intact DNA
(retained in the loading pocket) of the same sample at 8 ms exposure.
DNA fiber assay. For the analysis of DNA fiber length, cells were sequentially
pulse-labeled with 30 mM CldU (Sigma-Aldrich) and 250 mM IdU (European
Pharmacopoeia) for 30 min each. The cells were collected and resuspended in PBS
at 2.5 × 105 cells per ml. The labeled cells were diluted 1:1 (v/v) with unlabeled cells,
and 3 μl of cells were mixed with 7 μl of lysis buffer (200 mM Tris-HCl (pH 7.5),
50 mM EDTA, and 0.5% (w/v) SDS) on a glass slide. After 9 min, the slides were
tilted to 15–45°, and the resulting DNA spreads were air-dried and fixed in
methanol/acetic acid (3:1) solution overnight at 4°. The DNA fibers were denatured
with 2.5 M HCl for 60 min, washed several times with PBS to neutralize the pH,
and blocked with 0.1% Tween 20 in 2% BSA/PBS for 40 min. The newly replicated
CldU and IdU tracks were labeled for 2.5 h in the dark, at room temperature, with
anti-BrdU antibodies recognizing CldU (rat, Abcamab6326, 1:500) and IdU
(mouse, BD 347580 B44, 1:100), followed by 1 h incubation with secondary anti-
bodies at room temperature in the dark: anti-mouse Alexa Fluor 488 (1:300,
A11001, Invitrogen) and anti-rat Cy3 (1:150, 712-166-153, Jackson ImmunoR-
esearchLaboratories). Fibers were visualized on a Leica DMI 6000 inverted
microscope using an HCX Plan APO DIC 63x oil objective (1.4–0.6 NA) and
analyzed using Fiji75. At least 100 fibers were analyzed per replicate condition. Fork
speed in kb/min was calculated by multiplying the measured length in μm with a
conversion factor of 2.59 kb/μm and dividing by the duration of the labeling
pulse34.
Immunohistochemistry. Consecutive gastric formalin-fixed and paraffin-
embedded sections from six patients presenting with H. pylori-associated gastritis
and three patients with normal gastric mucosa were either stained with hema-
toxylin and eosin (H&E) or pretreated with CC1 buffer (Ventana Roche) for
16 min at 100 °C prior to staining with either Ki67 rabbit monoclonal antibody
(clone 30-9, Ventana Roche) or with anti-H. pylori polyclonal rabbit antibody
(B0471, Dako) for 30 min at 36 °C. Immunohistochemical staining and detection
were performed using the BenchMark Ultra system (Ventana Roche) and Opti-
View DAB IHC Detection kit (Roche). Slides were scanned using the Hamamatsu
Nanozoomer HAT scanner and analyzed using NDP.view version 2. The study was
approved by the Cantonal Ethics Committee of Zurich (KEK).
Western blotting. AGS cells were infected with H. pylori or treated as described
above for 6 h. Cells were harvested and lysed using 50 μl RIPA buffer (Sigma-
Aldrich, Cat. No. R0278-50ML) supplemented with 1× complete protease inhibitor
cocktail (Roche). Protein concentrations were determined using Bradford assay
(Bio-Rad, Cat No. 5000002) and equal amounts were separated by SDS/PAGE
(10% gel) followed by transfer onto nitrocellulose membranes (GE Healthcare Life
Sciences, Cat No. 10600023). Membranes were incubated with antibodies against β-
Actin (CST, 3700), p-KAP1 (S824) (Abcam, ab70369), and p-ATM (Abcam,
ab81292).
TCGA data analysis and annotation of H. pylori status. TCGA stomach ade-
nocarcinoma mutation and copy number data were downloaded with the R
package TCGAbiolinks76. Copy number thresholds were taken from the TCGA
CNV pipeline (−0.3 for loss and 0.3 for gain). Molecular subtyping was performed
based on a previous publication42. The Oncoprint-like plot was generated using the
R package ComplexHeatmap77. Damaging mutations were defined by having a
“deleterious” annotation from SIFT and “damaging” annotation from PolyPhen.
To annotate stomach adenocarcinoma (STAD) samples from TCGA with H. pylori
status, we acquired whole-genome (WGS), whole-exome (WXS), and tran-
scriptome (RNA-seq) sequencing data from TCGA via the application program-
ming interface (API) of the National Cancer Institute’s (NCI) Genomic Data
Commons (GDC). Raw sequencing data in bam format were screened for H. pylori
and other microbiota using the PathSeq pipeline78, which is available through the
Broad Institute’s Genome Analysis Tooklit (GATK v4.0.3). The PathSeq analysis
was performed using prebuilt human and microbial reference genomes from the
PathSeq resource bundle, available through the Broad Institute’s Genome Sequence
Archive (GSA) FTP server. All sequencing data were analyzed using a local high-
performance computing cluster. H. pylori status of a sample was determined by
having at least 1 unambiguous read in either WGS or RNAseq from the tumor
tissue or either WGS, WES, or RNAseq from normal adjacent tissue.
Statistics. All statistical analysis was performed using Graph Pad prism 5.0 soft-
ware. One-way ANOVA was used for statistical comparisons of groups of unequal
sizes, followed by Dunn’s multiple comparisons correction. Two-way ANOVA
with Tukey’s multiple comparisons correction was used wherever group sizes were
identical. P-values are indicated as follows: *, <0.05; **, <0.01; ***, <0.005; ****,
<0.001.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The source data underlying Figs. 1–7 and Supplementary Figs. 1–7 are provided as source
data files (Supplementary Data 1–13). All the other data supporting the findings of this
study are available within the article and its Supplementary Information files. A
Reporting Summary for this article is available as a Supplementary Information file.
Access to TCGA gastric cancer data is available through the link: https://gdc.cancer.gov/
about-data/publications/stad_2014.
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